Your search produced   results

NARROW YOUR CHOICES:

REPORTS:


CATEGORY:
All Categories
Clinical Development
Corporate Operations
Market Access
Market Intelligence
Marketing
Medical Affairs
Portfolio Management
Regulatory Affairs
Sales
Strategic Planning
Search:
 
YOUR SELECTIONS: Reports Only
 

  • PH68 Oncology Brand Commercialization ... Resource Allocation

    Allocate Resources for Oncology Brands Through Development and LaunchUse this report's 28 commercial variables to build your own, customized data sets for cancer drug launches. By combining spending and staffing data from the report's 28 different brand types, you can build resource benchmarks to fit your own unique challenges. The report's data sets are divided into 10 chapters:Chapter 1: Drug C [...]
     
    Type: reportCategories: Marketing

  • PH71 European Pharmaceutical Marketing ... Launching Successful Brands

    Launch successful European pharmaceutical brandsProducts progressing through the development pipeline to launch almost always require special resource allocations to overcome a unique blend of competitive pressures, clinical proficiency, commercial prospects, and regulatory hurdles. In order to meet sales expectations and achieve more explicit commercial objectives, drug companies must back their [...]
     
    Type: reportCategories: Marketing

  • PH78 Pharmaceutical Co-Promotion Management ... Leadership Structures, Sales Strategies, Budgets, Communication Links, and Coordination

    Pharmaceutical Co-Promotion ManagementCutting Edge Information has developed this study to research pharmaceutical co-promotions — and what makes them successful. Pharmaceutical Co-Promotion Management examines the inner workings of pharmaceutical co-promotions. From overall budgets and control to in the field strategies and tactics, this report details the inner workings of some of the industry [...]
     
    Type: reportCategories: Sales

  • PH162 Pharmaceutical Portfolio Management ... Selecting Targets, Filling Pipelines and Preparing for Post-Launch Success

    Prioritize, Support and Protect AssetsAmong life science companies, the drive to maximize core assets has never been more critical. An integral part of strategic planning, the portfolio management process influences decisions that directly impact company fortunes — especially when advancing the right compounds creates the potential for billions of dollars in long-term revenue.Effective portfolio [...]
     
    Type: reportCategories: Portfolio Management

  • PH80 Medical Devices Product Management ... Benchmarking Development, Marketing and Promotion

    Medical Device Product Data Throughout Development and Postmarket ManagementThis report provides qualitative information and quantitative benchmarks for three critical areas that concern all medical technology organizations:Investments, timelines and processes for medical device developmentMarketing organization structures, processes and benchmarksManagement of postmarket and field-based issues, i [...]
     
    Type: reportCategories: Marketing

  • PH82 Pharmaceutical Market Segmentation ... Spending, Strategy and Implementation

    Pharmaceutical Market Segmentation: Spending, Strategy and ImplementationCutting Edge Information developed this study to determine how companies use segmentation in marketing and promotion. Pharmaceutical Market Segmentation examines market segmentation budgets, structures, staffing, strategies and implementation to teach you how to either enact new segmentation plans or improve existing plans. F [...]
     
    Type: reportCategories: Sales

  • PH83 Small and Specialty Drug Branding ... Tapping Niche Market Potential

    Drive returns with specialty and niche brandsCommercializing new drugs continues to challenge companies across the pharmaceutical and biotechnology sectors. Cutting Edge Information published this study to assist individuals and product teams who seek guidance in the allocation of pre- and post-launch marketing resources for small and specialty brands.The information contained in this report is ba [...]
     
    Type: reportCategories: Marketing

  • PH84 Marketing Mid-Tier Pharmaceutical Brands ... Winning Resources for Near-Blockbusters

    Make the Most of Mid-Tier Pharma BrandsThe mid-level brands profiled in this study all fall short of reaching the $1 billion benchmark set by blockbuster drugs. However, global brand teams in charge of these drugs often reach their peak annual sales by investing far less money than their blockbuster counterparts. In many cases, mid-level, or sub-blockbuster drugs, are more profitable than blockbus [...]
     
    Type: reportCategories: Marketing

  • PH85 Blockbuster Pharmaceutical Launches ... Establishing Market Leadership

    Allocate Resources for Blockbuster Drug CommercializationThe blockbuster drug model drove the pharmaceutical industry to great heights for decades. In the current pharmaceutical market, however, blockbusters are becoming few and far between. In what can sometimes be a search for pharma's holy grail, the difference between discovering a blockbuster and the next me-too product often comes down to ex [...]
     
    Type: reportCategories: Marketing

  • PH86 Pharmaceutical CME ... Measuring Program Effectiveness in the Compliance Environment

    Pharmaceutical CME: Measure Performance, Effectiveness and ROI Pharmaceutical CME departments struggle to measure performance for a number of reasons. The lack of hard measures for medical education, along with a fear of appearing non-compliant stops many companies from tracking return on investment (ROI). Many medical education departments use post-CME outcomes measures to judge the effectivenes [...]
     
    Type: reportCategories: Medical Affairs